Psoriasis Does Not Typically Present with Thrombocytopenia as a Disease Feature
Psoriasis itself does not cause thrombocytopenia; in fact, patients with psoriasis typically have elevated platelet counts due to the chronic inflammatory state. 1 If thrombocytopenia is present in a psoriasis patient, you should immediately investigate alternative causes, particularly drug-induced thrombocytopenia from biologic therapies.
Understanding the Platelet Profile in Psoriasis
The inflammatory nature of psoriasis actually drives platelet production upward, not downward:
- Patients with psoriasis have significantly higher platelet counts compared to controls (mean difference of 12.86 × 10⁹/L higher) 1
- Mean platelet volume (MPV) and plateletcrit (PCT) are also elevated in psoriasis patients 1
- These elevations correlate weakly with disease severity as measured by PASI scores 1
The National Psoriasis Foundation guidelines recognize psoriasis as a multisystem inflammatory disorder associated with cardiovascular disease, psoriatic arthritis, metabolic syndrome, and depression, but thrombocytopenia is not listed among the recognized comorbidities 2.
When Thrombocytopenia Occurs: Drug-Induced Causes
If you encounter thrombocytopenia in a psoriasis patient, the most likely culprit is biologic therapy:
Anti-TNF-α Agents
- Frequency: 4.3% of patients develop drug-induced thrombocytopenia during anti-TNF-α therapy 3
- Platelet counts decrease by approximately 17-18% during adalimumab and infliximab therapy 4
- Recovery typically occurs after drug suspension, with relapse upon re-exposure 3
Efalizumab (Historical)
- Previously associated with thrombocytopenia, though this drug is no longer available 5
- Required monthly platelet monitoring for the first 6 months of therapy 5
Clinical Monitoring Algorithm
When administering biologics to psoriasis patients:
- Check baseline platelet count before initiating therapy
- Monitor monthly during the first 3-6 months of biologic therapy 4, 5
- Increase monitoring frequency if platelet count trends downward
- Exercise heightened caution in patients with:
- Chronic liver disease (especially alcoholic cirrhosis) 4
- Baseline thrombocytopenia from any cause
- Concurrent medications that affect platelet counts
Critical Pitfall to Avoid
Do not attribute thrombocytopenia to psoriasis itself. The presence of low platelets in a psoriasis patient demands investigation for:
- Drug-induced causes (biologics, methotrexate, other immunosuppressants)
- Underlying liver disease
- Concurrent autoimmune conditions
- Hematologic disorders
- Infection-related causes
The inflammatory state of psoriasis creates a prothrombotic environment with elevated platelet counts, not thrombocytopenia. Missing an alternative diagnosis could delay appropriate treatment and increase morbidity risk, particularly bleeding complications in patients with severe thrombocytopenia.